Summary
In this review we describe angiogenesis pathways involved in the development of breast carcinoma. Different assessment techniques for angiogenesis and their optimisation are discussed. Angiogenesis is an important factor for prognosis and will be increasingly important in therapeutic decisions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albo, D., Granick, M., Jhala, N., Atkinson, B. and Solomon, M. (1994) The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann. Plast. Surg. 32:558–594.
Alexander, CM. and Werb, Z. (1991) Extracellular matrix degradation. In: E.D. Hay, (ed.) Cell biology of extracellular matrix. Plenum Press, New York, 255–302.
Alvarez, J.A., Baird, A., Tatum, A., Daucher, J., Chorsky, R., Gonzalez, A.M. and Stopa, E.G. (1992) Localization of basic fibroblast growth factor in human glial neoplasms. Mod. Pathol. 5(3):303–307.
Anandappa, S.Y., Winstanley, J.H., Leister, S., Green, B., Rudland, P.S. and Barraclough, R. (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer 69(4): 772–776.
Andrade, S.P, Fan, TP. and Lewis, G.P. (1987) Quantitative in vivo studies on angiogenesis in a rat sponge model. Br. J. Exp. Pathol. 68(6): 755–766.
Antonie, J. and Rakar, S. (1995) Colour and pulsed doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses. Anticancer Res. 15:1527–1532.
Aruffo, A., Dietsch, M.T., Wan, H., Hellstrom, K.E. and Hellstrom, I. (1992) Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc. Natl. Acad. Sci. USA 89(6): 2292–2296.
Auerbach, R., Arensman, R., Kubai, L. and Folkman, J. (1975) Tumor induced angiogenesis: lack of inhibition by irradiation. Int. J. Cancer 15 (2): 241–245.
Axelsson, K., Ljung, B.E., Moore, D.H. 2nd., Thor, A.D., Chew, K.L., Edgerton, S.M., Smith, H.S. and Mayall, B.H. (1995) Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. 87(13): 997–1008.
Bamber, J.C,, G.L., Cosgrove, D.O., Simmons, P., Davey, J. and McKinna, J.A. (1988) Quantitative evaluation of real-time ultrasound features of the breast. Ultrasound Med. Biol. 1(81):81–87.
Banks, R.E., Gearing, A.J., Hemingway, I.K., Norfolk, D.R., Perren, T.J. and Selby, PJ. (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br. J. Cancer 68(1): 122–124.
Barbareschi, M., Weidner, N., Gasparini, G., Morelli, L., Forti, S., Eccher, C, Fina, P., Caffo, O., Leonardi, E., Mauri, F., Bevilacqua, P. and Dalla Palma, P. (1995) Microvessel quantitation in breast carcinomas. Appl Immunochem. 3 (2): 75–84.
Barnhill, R.L., Fandrey, K., Levy, M.A., Mihm, M.J. and Hyman, B. (1992a) Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocyte nevi and cutaneous malignant melanoma. Lab. Invest. 67(3): 331–337.
Barnhill, R.L., Mihm, M.J. and Ceballos, P.I. (1992b) Angiogenesis and regressing cutaneous malignant melanoma [letter]. Lancet 339(8799): 991–992.
Barnhill, R., Busam, K., Berwick, M., Blessing, K., Cochran, A., Elder, D., Fandrey, K., Karaoli, T. and White, W. (1994) Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet 344:1237–1238.
Barton, G.J., Ponting, CP, Spraggon, G., Finnis, C. and Sleep, D. (1992) Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine Phosphorylase. Protein Science 1:688–690.
Berkman, R.A., Merrill, M.J., Reinhold, W.C, Monacci, W.T., Saxena, A., Clark, W.C, Robertson, J.T., Ali, I.U. and Oldfield, E.H. (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91 (1): 153–159.
Bigler, S., Deering, R. and Brawer, M. (1993) Comparisons of microscopic vascularity in benign and malignant prostate tissue. Hum. Pathol. 24:220–226.
Birkedal, H.H. Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal, H.B., De, CA. and Engler, J.A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4(2): 197–250.
Bischoff, J. (1995) Approaches to studying cell adhesion molecules in angiogenesis. Trends in Cell Biology 5:69–74.
Blann, A.D. and McCollum, C.N, (1994) Circulating endothelial-cell leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 72(1):151–154.
Blood, C.H. and Zetter, B.R. (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032 (1):89–118.
Boocock, CA., Charnock, J.D., Sharkey, A.M., McLaren, J., Barker, P.J., Wright, K.A., Twentyman, PR. and Smith, S.K. (1995) Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J. Natl. Cancer Inst. 87(7):506–516.
Bosari, S., Lee, A.K., DeLellis, R.A., Wiley, B.D., Heatley, G.J. and Silverman, M.L. (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol. 23(7):755–761.
Bouck, N. (1990) Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2(6): 179–185.
Boveri, T. (1929) The origin of malignant tumors. Williams and Wilkins, Baltimore.
Brawer, M.K., Deering, R.E., Brown, M., Preston, S.D. and Bigler, S.A. (1994) Predictors of pathologic stage in prostatic carcinoma. The role of neovascularization. Cancer 73(3):678–687.
Brem, S., Cotran, R. and Folkman, J. (1972) Tumor angiogenesis: a quantitative method for histological grading. J. Natl. Cancer Inst. 48:347–356.
Brem, S.S., M., J.H. and Gullino, P.M. (1978) Angiogenesis as a marker of pre-neoplastic lesions of the human breast. Cancer 41:239–248.
Briozzo, P., Morisset, M., Capony, F., Rougeot, C. and Rochefort, H. (1988) In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 48:3688–3692.
Britton, P.D. and Coulden, R.A. (1990) The use of duplex Doppler ultrasound in the diagnosis of breast cancer. Clin. Radiol. 42 (6): 399–401.
Brooks, P.C., Clark, R.A. and Cheresh, D.A. (1994a) Requirement of vascular integrin αvß3 for angiogenesis. Science 264(5158): 569–571.
Brooks, P.C., Montgomery, A.M., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G. and Cheresh, D.A. (1994b) Integrin αvß3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7): 1157–1164.
Brooks, P.C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F.H. and Cheresh, D.A. (1995) Antiintegrin αvß3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96:1815–1822.
Brown, L.F., Yeo, K.T., Berse, B., Yeo, T.K., Senger, DR., Dvorak, H.F. and Van, d. W.L. (19992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176(5): 1375–1379.
Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Dvorak, H.F. and Senger, D.R. (1993 a) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143(5): 1255–1262.
Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R. and Dvorak, H.F. (1993 b) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53(19):4727–4735.
Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Guidi, A.J., Dvorak, H.F., Senger, D.R., Connolly, J.L. and Schnitt, S.J. (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26(1): 86–91.
Bundred, N., Bowcott, M., Walls, J., Faragher, E. and Knox, F. (1994) Angiogenesis in breast cancer predicts node metastasis and survival. Br. J. Surgery 81:768 (Abstract).
Burns, P.N., Halliwell, M, Wells, P.N. and Webb, A.J. (1982) Ultrasonic Doppler studies of the breast. Ultrasound Med. Biol. 8(2): 127–143.
Burrows, F.J. and Thorpe, P.E. (1994) Vascular targeting — a new approach to the therapy of solid tumors. Pharmacol. Ther. 64(1): 155–74.
Byrne, J.A., Tomasetto, C, Rouyer, N., Bellocq, J.-P, Rio, M.-C. and Basset, P. (1995) The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expression. Molecular Medicine 1(4):418–427.
Camochan, P., Briggs, J.C., Westbury, G. and Davies, A.J. (1991) The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85–1.25 mm in thickness. Br. J. Cancer 64(1): 102–107.
Chalkley, H. (1943) Method for the quantitative morphological analysis of tissues. J. Nat. Cancer Inst. 4:47–53.
Charpin, C, Devictor, B., Bergeret, D., Andrac, L., Boulat, J., Horschowski, N., Lavaut, M.N. and Piana, L. (1995) CD31 Quantitative immunocytochemical assays in breast carcinomas. Am. J. Clin. Pathol. 103:443–448.
Clarke, C.L. and Sutherland, R.L. (1990) Progestin regulation of cellular proliferation. Endocr. Rev. 11 (2): 266–301.
Clezardin, P., Frappart, L., Clerget, M., Pechoux, C. and Delmas, P.D. (1993) Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res. 53 (6): 1421–1430.
Cockerell, C.J., Sonnier, G., Kelly, L. and Patel, S. (1994) Comparative analysis of neovascularisation in primary cutaneous melanoma and Spitz nevus. Am. J. Dermatopathol.16:9–13.
Cosgrove, D.O., Bamber, J.C., Davey, J.B., McKinna, J.A. and Sinnett, H.D. (1990) Color Doppler signals from breast tumors. Work in progress. Radiology 176(1): 175–180.
Cosgrove, D.O., Kedar, R.P, Bamber, J.C., Al, M.B., Davey, J.B., Fisher, C, McKinna, J.A., Svensson, W.E., Tohno, E., Vagios, E. et al. (1993) Breast diseases: color Doppler US in differential diagnosis [see comments]. Radiology 189(1):99–104.
Costa, M., Danesi, R., Agen, C, Di, P.A., Basolo, F., Del, B.S. and Del, T.M. (1994) MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery. Cancer Res. 54(1): 9–11.
Daa, T., Kodama, M., Kashima, K., Yokoyama, S., Nakayama, I. and Noguchi, S. (1993) Identification of basic fibroblast growth factor in papillary carcinoma of the thyroid. Acta Pathol. Jpn. 43 (10): 582–589.
Dameron, K.M., Volpert, O.V and Bouck, N. (1994a) The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor Symp. Quant. Biol. 54:1–7.
Dameron, K.M., Volpert, O.V, Tainsky, M.A. and Bouck, N. (1994b) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265 (5178): 1582–1584.
de Fougerolles, A., Stacker, S.A., Schwarting, R. and Springer, T.A. (1991) Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174(1): 253–267.
Denton, K.J., Stretch, J.R., Gatter, K.C. and Harris, A.L. (1992) A study of adhesion molecules as markers of progression in malignant melanoma. J. Pathol. 167(2): 187–191.
deVries, C, Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N. and Williams, L.T. (1992) The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 (5047): 989–991.
Dickinson, A.J., Fox, S.B., Persad, R.A., Hollyer, J., Sibley, G.N. and Harris, A.L. (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br. J. Urol. 76(6): 762–766.
DiPietro, L.A. and Polverini, P.J. (1993) Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am. J. Pathol. 143 (3): 678–684.
Dixon, J.M., Walsh, J., Paterson, D. and Chetty, U. (1992) Colour Doppler ultrasonography studies of benign and malignant breast lesions. Br. J. Surgery 79(3): 259–260.
Dock, W. (1993) Duplex sonography of mammary tumors: a prospective study of 75 patients. J. Ultrasound Med. 12(2):79–82.
Doussis, A.I., Kaklamanis, L., Cordell, J., Jones, M., Turley, H., Pulford, K., Simmons, D., Mason, D. and Gatter, K. (1993) ICAM-3 expression on endothelium in lymphoid malignancy. Am. J. Pathol. 143(4): 1040–1043.
Duffy, M., Reilly, D., O’Sullivan, C, O’Higgins, N., Fennelly, J.J. and Andreasen, P. (1990) Urokinase, plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res. 50:6827–6829.
Duggan, C, Maguire, T., McDermott, E., O’Higgins, N., Fennelly, J.J. and Duffy, M.J. (1995) Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int. J. Cancer 61 (5): 597–600.
Dvorak, H.F. (1987) Thrombosis and cancer. Hum. Pathol. 18(3): 275–284.
Dvorak, H.F., Sioussat, T.M., Brown, L.F., Berse, B., Nagy, J.A., Sotrel, A., Manseau, E.J., Van, d. W.L. and Senger, D.R. (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174(5): 1275–1278.
Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A, Tanaka, Y, Wada, K and Ishitsuka, H. (1993) Cytokines induce thymidine Phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol. 32:333–338.
Elledge, R.M. and Lee, W.-H. (1995) Life and death by 53. Bioessays 17(11):923–930.
Engels, K., Fox, S.B., Gatter, K.C. and Harris, A.L. (1996) Distinct angiogenic patterns are associated with high grade in-situ ductal carcinoma of the breast. J. Pathol, in press.
Erikson, A. (1989) Biosynthesis of lysosomal endopeptidases. J. Cell Biochem. 40:31–41.
Ethier, S.P. (1995) Growth factor synthesis and human breast cancer progression. J. Natl. Cancer Inst. 87(13):964–973.
Fan, T.-PD. Frost, E.E. and Wren, A.D. (19992) A multichannel wounding device for the study of vascular repair in vitro. In: M.E. Maragoudakis, P. Gullino, and P.T. Lelkes, (eds): Angiogenesis in health and disease. Plenum Press, New York, pp 315–320.
Fawcett, J., Holness, C.L., Needham, L.A., Turley, H., Gatter, K.C., Mason, D.Y. and Simmons, D.L. (1992) Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 360(6403):481–484.
Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61 (5): 759–767.
Ferrara, N. (1995) Leukocyte adhesion. Missing link in angiogenesis [news; comment]. Nature 376(6540).
Ferrara, N., Houck, K., Jakeman, L. and Leung, D.W. (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13(1): 18–32.
Finnis, C, Dodsworth, N., Pollitt, CE., Carr, G. and Sleep, D. (1993) Thymidine Phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur. J. Biochem. 212(1): 201–210.
Foekens, J.A., Schmitt, M., van, P.W., Peters, H.A., Bontenbal, M., Jänicke, F. and Klijn, J.G. (1992) Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res. 52(21): 6101–6105.
Foekens, J.A., Schmitt, M., van, P.W., Peters, H.A., Kramer, M.D., Jänicke, F. and Klijn, J.G. (1994) Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J. Clin. Oncol 12(8): 1648–1658.
Foekens, J.A., Buessecker, F., Peters, H.A., Krainick, U, van, P.W., Look, M.P., Klijn, J.G. and Kramer, M.D. (1995) Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res. 55(7): 1423–1427.
Folberg, R., Rummelt, V, Ginderdeuren, R.-V, Hwang, T., Woolsen, R., Pe’er, J. and Gruman, L. (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100:1389–1398.
Folkman, J. and Hochberg, M. (1973) Self-regulation of growth in three dimensions. J. Exp. Med. 138(4):745–753.
Folkman, J., Weisz, P.B., Joullie, M.M., Li, W.W. and Ewing, W.R. 1989) Control of angiogenesis with synthetic heparin substitutes. Science 243(4897): 1490–1493.
Fong, G.-H., Rossant, J., Gertsenstein, M. and Breitman, M.L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66–70.
Foulds, L. (1958) The natural history of cancer. J. Chronic Dis. 8:2–37.
Fox, S.B., Gatter, K.C., Bicknell, R., Going, J.J., Stanton, P., Cooke, T.G. and Harris, A.L. (1993 a) Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 53(18):4161–4163.
Fox, S.B., Stuart, N., Smith, K., Brunner, N. and Harris, A.L. (1993b) High levels of uPA and PAI-1 are associated with highly angiogenic breast carcinomas. J. Pathol. 170 (suppl.):388A.
Fox, S.B., Leek, R., Smith, K., Hollyer, J., Greenall, M. and Harris, A. (1994) Tumor angiogenesis in node negative breast carcinomas-relationship to epidermal growth factor receptor and survival. Breast Cancer Res. Treat. 29:109–116.
Fox, S.B., Leek, R.D., Weekes, M.P, Whitehouse, R.M., Gatter, K.C. and Harris, A.L. (1995 a) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J. Pathol, in press.
Fox, S.B., Turner, G., Gatter, K. and Harris, A. (1995 b) The increased expression of adhesion molecules ICAM-3, E and P selectin on breast cancer endothelium. J. Pathol, in press.
Fox, S.B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R.M., Bicknell, R., Gatter, K.C. and Harris, A.L. (1995 c) The angiogenic factor platelet derived endothelial cell growth factor/thymidine Phosphorylase is upregulated in breast cancer epithelium and endothelium. Br. J. Cancer, in press.
Frater-Schroder, M., Risau, W, Hallmann, R., Gautschi, P. and Bohlen, P (1987) Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84(15):5277–5281.
Frixen, U.H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D. and Birchmeier, W. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol 113(1): 173–185.
Frouge, C, Guinebretiere, J.M., Contesso, G., Di, PR. and Blery, M. (1994) Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest. Radiol 29(12): 1043–1049.
Fujimoto, K., Ichimori, Y., Kakizoe, T, Okajima, E., Sakamoto, H., Sugimura, T. andTerada, M. (1991) Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem. Biophys. Res. Comm. 180:386–392.
Furukawa, T, Yoshimura, A., Sumizawa, T., Haraguchi, M. and Akiyama, S.I. (1992) Angiogenic factor. Nature 356:668.
Furusato, M., Wakui, S., Sasaki, H., Ito, K. and Ushigome, S. (1994) Tumour angiogenesis in latent prostatic carcinoma. Br. J. Cancer 70(6): 1244–1246.
Galland, F., Karamysheva, A., Mattei, M.G., Rosnet, O., Marchetto, S. and Birnbaum, D. (1992) Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 13(2):475–478.
Galland, F., Karamysheva, A., Pebusque, M.J., Borg, J.P, Rottapel, R., Dubreuil, P., Rosnet, O. and Birnbaum, D. (1993) The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8(5): 1233–1240.
Gamble, J.R., Matthias, L.J., Meyer, G., Kaur, P., Russ, G., Faull, R., Berndt, M.C. and Vadas, M.A. (1993) Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 121(4):931–943.
Ganesh, S., Sier, C.F.M., Heerding, M.M., Griffioen, G., Lamers, C.B.H.W. and Verspaget, H.W. (1994) Urokinase receptor and colorectal cancer survival. Lancet 344:401–402.
Garver, R.J., Radford, D.M., Donis, K.H., Wick, M.R. and Milner, P.G. (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74(5):1584–1590.
Gimbrone, M.A.J., Cotran, R., Leapman, S. and Folkman, J. (1974) Tumour growth neovas-cularization: An experimental model using rabbit cornea. J. Natl Cancer Inst. 52: 413–427.
Gimbrone, M.J. and Gullino, P.M. (1976 a) Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation. Cancer Res. 36: 2611–2620.
Gimbrone, M.J. and Gullino, P.M. (1976b) Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues. J. Natl. Cancer Inst. 56(2):305–318.
Glukhova, M., Koteliansky, V, Sastre, X. and Thiery, J.P. (1995) Adhesion systems in normal breast and in invasive breast carcinoma. Am. J. Pathol. 146(3): 706–716.
Goldberg, M.A. and Schneider, T.J. (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269(6):4355–4359.
Gomm, J.J., Smith, J., Ryall, G.K., Ballic, R., Turnbull, L. and Coombes, R.C. (1991) Localisation of basic fibroblast growth factor and transforming growth factor b 1 in the human mammary gland. Cancer Res. 51:4685–4692.
Good, D.J., Polverini, P.J., Rastinejad, F., Le, B.M., Lemons, R.S., Frazier, W.A. and Bouck, N.P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87(17): 6624–6628.
Grischke, E.M., Kaufmann, M., Eberlein-Gonska, M., Mattfeld, T., Sohn, C. and Bastert, G. (1994) Angiogenesis as a diagnostic factor in primary breast cancer: microvessel quantitation by stereological methods and correlation with color doppler sonography. Onkologie 17:34–42.
Grondahl, HJ., Christensen, I.J., Rosenquist, C, Brunner, N., Mouridsen, H.T., Daño, K. and Blichert, T.M. (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res. 53(11):2513–2521.
Guidi, A., Fischer, L., Harris, J. and Schnitt, S. (1994) Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 86:614–619.
Guidi, A.J., Abu-Jawdeh, G., Berse, B., Jackman, R.W., Tognazzi, K., Dvorak, H.F. and Brown, F.F. (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst. 87 (16): 1237–1245.
Guinebretiere, J.M., Le, M.G., Gavoille, A., Bahi, J. and Contesso, G. (1994) Angiogenesis and risk of breast cancer in women with fibrocystic disease [letter; comment].J. Natl. Cancer Inst. 86(8):635–636.
Haldar, S., Negrini, M., Monne, M., Sabbioni, S. and Croce, CM. (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 53 (8): 2095–2097.
Hall, N.R., Fish, D.E., Hunt, N., Goldin, R.D., Guillou, P.J. and Monson, J.R. (1992) Is the relationship between angiogenesis and metastasis in breast cancer real? Surg. Oncol. 1(3): 223–229.
Hanneken, A., Maher, P. and Baird, A. (1995) High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells-implications for the modulation of FGF-2. J. Cell Biol. 128:1221–1228.
Haraguchi, M., Kazutaka, M., Uemura, K, Sumizawa, T., Furukawa, T., Yamada, K. and Akiyama, S.-I. (1994) Angiogenic activity of enzymes. Nature 368:198.
Heywang, K.S. (1994) Contrast-enhanced magnetic resonance imaging of the breast. Invest. Radiol. 29(1):94–104.
Heywang, K.S., Schlegel, A., Beck, R., Wendt, T., Kellner, W., Lommatzsch, B., Untch, M. and Nathrath, W.B. (1993) Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J. Comput. Assist. Tomogr. 17 (6): 891–900.
Heywang, K.S., Haustein, J., Pohl, C, Beck, R., Lommatzsch, B., Untch, M. and Nathrath, W.B (1994) Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 191 (3): 639–646.
Ho, CK, Ou, B.R., Hsu, M.L., Su, S.N., Yung, C.H. and Wang, S.Y. (1990) Induction of thymidine kinase activity and clonal growth of certain leukemic cell lines by granulocyte- derived factor. Blood 75(12):2438–2444.
Hockenbery, D.M. (1995) bcl-2, a novel regulator of cell death. Bioessays 17 (7):631–638.
Hogg, N. and Landis, R.C. (1993) Adhesion molecules in cell interactions. Curr. Opin. Immunol. 5(3):383–390.
Holmgren, L., O’Reilly, M.S. and Folkman, J. (1995) Dormancy of micrometastasi s: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1(2): 149–153.
Horak, E.R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K. and Harris, A.L. (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 240(8828): 1120–1124.
Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J. and Ferrara, N. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267(36): 26031–26037.
Hunt, T.K., Knighton, D.R., Thakral, K.K., Goodson, W.3. and Andrews, W.S. (1984) Studies on inflammation and wound healing angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 96(1): 48–54.
Iozzo, R.V (1995) Tumor stroma as a regulator of neoplastic behaviour. Lab. Invest. 73:157–160.
Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C, Hagiwara, K., Usuki, K., Takaku, F, Risau, W. and Heldin, C.H. (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 33(6216):557–562.
Iwata, H., Kobayashi, S., Iwase, H. and Okada, Y. (1995) [The expression of MMPs andTIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis]. Nippon Rinsho 53(7): 1805–1810.
Jackson, VP. (1988) Duplex sonography of the breast. Ultrasound Med. Biol. 1 (131): 131–137.
Jaeger, T, Weidner, N., Chew, K., Moore, D., Kerschman, R., Carrol, P. and Waldman, F. (1994) Tumor angiogenesis predicts lymph node metastasis in invasive bladder cancer. Proc. Am. Assoc. Cancer Res. 35:66 (abstract 394).
Jain, R.K. (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9 (3): 253–266.
Jain, R.K. (1994) Barriers to drug delivery in solid tumors. Sci. Am. 271 (1): 58–65.
Jänicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Hofler, H. and Graeff, H. (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat. 24(3): 195–208.
Janot, F., el-Naggar, A.K., Morrison, R.S., Liu, T.J., Taylor, D.L. and Clayman, G.L. (1995) Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int. J. Cancer 64(2): 117–123.
Jellins, J. (1988) Combining imaging and vascularity assessment of breast lesions. Ultrasound Med. Biol. 1(121): 121–130.
Kageshita, T, Yoshii, A., Kimura, T, Kuriya, N., Ono, T, Tsujisaki, M. Imai, K. and Ferrone, S. (1993) Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res. 53:4927–4932.
Kaipainen, A., Korhonen, J., Pajusola, K., Aprelikova, O., Persico, M.G., Terman, B.I. and Alitalo, K. (1993) The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178(6):2077–2088.
Kaiser, W.A. (1993) [MR mammography]. Radiologie 33(5):292–299.
Kaiser, W.A., Diedrich, K., Reiser, M. and Krebs, D. (1993) [Modern diagnostics of the breast]. Geburtshilfe Frauenheilkd. 53 (1): 1–14.
Kandel, J., Bossy, W.E., Radvanyi, F., Klagsbrun, M., Folkman, J. and Hanahan, D. (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66(6): 1095–104.
Kaplanski, G., Farnarier, C, Benoliel, A., Foa, C, Kaplanski, S. and Bongrand, P. (1994) A novel role for E- and P-selectins: shape of endothelial cell monolayers. J. Cell Sci. 107:2449–2457.
Kendall, R.L. and Thomas, K.A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90(22): 10705–10709.
Kieser, A., Weich, H.A., Brandner, G., Marme, D. and Kolch, W. (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9 (3): 963–969.
Knighton, D., Ausprunk, D., Tapper, D. and Folkman, J. (177) Avascular and vascular phases of tumour growth in the chick embryo. Br. J. Cancer 35 (3): 347–356.
Koch, A.E., Cho, M., Burrows, J.C., Polverini, P.J. and Leibovich, S.J. (1992) Inhibition of production of monocyte/macrophage-derived angiogenic activity by oxygen free-radical. scavengers. Cell Biol Int. Rep. 16(5):415–425.
Kondo, S., Asano, M., Matsuo, K, Ohmori, I. and Suzuki, H. (1994) Vascular endothelial growth factor/(vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta 1221 (2): 211–214.
Kristensen, P., Larsson, L., Nielsen, L., Grondahl-Hansen, J., Andeasen, P. and Dano, K.(1994) Human endothelial cells contain one type of plasminogen activator. FEBS Lett. 168:33–37.
Kuzu, I., Bicknell, R., Harris, A.L., Jones, M, Gatter, K.C. and Mason, D.Y. (1992) Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J. Clin. Pathol. 45(2): 143–148.
Lakhani, S.R., Collins, N., Stratton, M.R. and Sloane, J.P. (1995) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16 q and 17 p. J. Clin. Pathol. 48:611–615.
Lampugnani, M.G., Resnati, M., Dejana, E. and Marchisio, P.C. (1991) The role of integrins in the maintenance of endothelial monolayer integrity. J. Cell Biol 112(3): 479–490.
Larsson, K., Skriver, L., Nielsen, J., Grondahl-Hansen, J., Kristensen, P. and Dano, K. (1984) Distribution of urokinase-type activator immunoreactivity in the mouse. J. Cell Biol 98:894–903.
Lauk, S., Zietman, A., Skates, S., Fabian, R. and Suit, H.D. (1989) Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res. 49(16): 4557–4561.
Leavesley, D.I., Schwartz, M.A., Rosenfeld, M. and Cheresh, D.A. (1993) Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121(1):163–170.
Leek, R.D., Harris, A.L. and Lewis, CE. (1994) Cytokine networks in solid human tumors: regulation of angiogenesis. J. Leukoc. Biol. 56(4): 423–435.
Li, V, Folkerth, R., Watanabe, H., Yu, C, Rupnick, M., Barnes, P., Scott, R., Black, P., Sallan, S. and Folkman, J. (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82–86.
Liotta, L.A., Kleinerman, J. and Saidel, G.M. (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res. 34:997–1004.
Liotta, L.A., Steeg, P.S. and Stetler, S.W. (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64(2): 327–336.
Lochter, A. and Bissell, M.J. (1995) Involvement of extracellular matrix constituents in breast cancer. Cancer Biol. 6:165–1773.
Macchiarmi, P., Fontanini, G., Hardin, M.J., Squartini, F. and Angeletti, CA. (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 240(8812): 145–146.
Macchiarini, P., Fontanini, G., Dulmet, E., de Montepreville, V, Chapelier, A., Cerrina, J., Ladurie, F.-R. and Darteville, P. (1994) Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. Ann. Thor. Surg. 57: 1534–1539.
Maiorana, A. and Gullino, P.M. (1978) Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. Cancer Res. 38 (12): 4409–4414.
Matrisian, L.M. (1992) The matrix-degrading metalloproteinases. Bioessays 14 (7): 455–463.
Mattern, J., Koomägi, R. and Volm, M. (1995) Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int. J. Oncology 6:1059–1062.
McCarthy, S.A., Kuzu, I., Gatter, K.C. and Bicknell, R. (1991) Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol. Sci. 12(12):462–467.
Millauer, B., Wizigmann, VS., Schnurch, H., Martinez, R., Moller, N.P., Risau, W. and Ullrich, A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72(6): 835–846.
Minchenko, A., Bauer, T., Salceda, S. and Caro, J. (19994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71:374–379.
Mitchell, B.S. Schumacher, U. and Kaiserling, E. (1994) Are tumours innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 9.5 (PGP 9.5) in benign, malignant and experimental tumours. Tumour Biol. 15(5):269–274.
Miyazono, K., Usuki, K. and Heldin, C.H. (1991) Platelet-derived endothelial cell growth factor. Prog. Growth Factor Res. 3 (3): 207–217.
Mlynek, M., van Beunigen, D., Leder, L.-D. and Streffer, D. (1985) Measurement of the grade of vascularisation in histological tumour tissue sections. Br. J. Cancer 52:945–948.
Moffett, B.F, Baban, D., Bao, L. and Tarin, D. (1992) Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker. Cancer Res. 52(7): 1737–1743.
Moghaddam, A. and Bicknell, R. (1992) Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine Phosphorylase activity. Biochemistry 31 (48): 12141–12146.
Moghaddam, A., Zhang, H.T., Fan, TP, Hu, D.E., Lees, VC, Turley, H., Fox, S.B., Gatter, K.C, Harris, A.L. and Bicknell, R. (1995) Thymidine Phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA 92 (4): 998–1002.
Montesano, R. (1992) 1992 Mack Forster Award Lecture. Review. Regulation of angiogenesis in vitro. Eur. J Clin. Invest. 22(8): 504–515.
Morris, P.B., Ellis, M.N. and Swain, J.L. (1989) Angiogenic potency of nucleotide meta-bolites: potential role in ischemia-induced vascular growth. J. Mol. Cell. Cardiol. 21(4): 351–358.
Moutcourrier, P., Manreat, PH., Salazar, G., Morisset, M., Sahuquet, A. and Rochefort, H. (1990) Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res. 50:6045–6054.
Mukhopadhyay, D., Tsiokas, L., Zhou, X.M., Foster, D., Brugge, J.S. and Sukhatme, VP. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375 (6532): 577–581.
Nelson, H., Ramsey, P., Donohue, J. and Wold, L. (1994) Cell adhesion molecule expression within the microvasculature of human colorectal malignancies. Clin. Immunol. Immunpathol. 72:129–136.
Nguyen, M., Strubel, N.A. and Bischoff, J. (1993 a) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365 (6443): 267–269.
Nguyen, M., Watanabe, H., Budson, A.E., Richie, J.P and Folkman, J. (1993 b) Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst. 85 (3): 241–242.
Nguyen, M., Watanabe, H., Budson, A.E., Richie, J.P, Hayes, D.F and Folkman, J. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers [see comments]. J. Natl. Cancer Inst. 86(5): 356–361.
Nunez, G. and Clarke, M.F. (1994) The bcl-2 family of proteins: regulators of cell death and survival. Trends in Cell Biology 4:399–403.
Nystrom, C, Forssman, L. and Roos, B. (1969) Myometrial blood flow studies in carcinoma of the corpus uteri. Acta Radiol. Ther. 8:193–198.
O’Brien, T, Cranston, D., Fuggle, S., Bicknell, R. and Harris, A.L. (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55 (3): 510–513.
O’Reilly, M.S., Holmgen, L., Shing, Y., Chen, C, Rosenthal, R.A., Moses, M., Lane, WS., Cao, Y, Sage, E.H. and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments]. Cell 79(2):315–328.
O’Sullivan, C, Lewis, CE., Harris, A.L. and McGee, J.O. (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342(8864): 148–149.
Ogawa, Y, Chung, Y, Nakata, B., Takatsuka, S., Yamashita, Y, Maeda, K., Sawada, T, Kato, Y, Fujimoto, Y, Yoshikawa, K. and Sowa, M. (1994) An evaluation of angiogenesis in breast cancer with factor VIII related antigen staining. Proc. Am. Assoc. Cancer Res. 35:186 (abstr. 1113).
Ohsawa, M., Tornita, Y, Kuratsu, S., Kanno, H. and Aozasa, K. (1995) Angiogenesis in malignant fibrous histiocytoma. Oncology 52:51–54.
Olivarez, D., Ulbright, T., DeRiese, W., Foster, R., Reister, T., Einhorn, L. and Sledge, G. (1994) Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res. 54:2800–2802.
Olson, T. A., Mohanraj, D., Carson, L.F. and Ramakrishnan, S. (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 54(1): 276–280.
Ottinetti, A. and Sapino, A. (1988) Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res. Treat. 11:241–248.
Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R. and Alitalo, K. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines [published erratum appears in Cancer Res. 1993 Aug 15, 53 (16):3845]. Cancer Res. 52(20):5738–5743.
Pajusola, K., Aprelikova, O., Pelicci, G., Weich, H., Claesson, W.L. and Alitalo, K. (1994) Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9(12): 3545–3555.
Paku, S. and Lapis, K. (1993) Morphological aspects of angiogenesis in experimental liver metastases. Am. J. Pathol. 143 (3): 926–936.
Palabrica, T., Lobb, R., Furie, B.C., Aronovitz, M., Benjamin, C, Hsu, Y.M., Sajer, S.A. and Furie, B. (1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359(6398):848–851.
Park, J.E., Chen, H.H., Winer, J., Houck, K.A. and Ferrara, N. (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-l/KDR. J. Biol. Chem. 269(41):25646–25654.
Parums, D., Cordell, J., Micklem, K., Heryet, A., Gatter, K. and Mason, D. (1990) JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 43:752–757.
Patterson, A., Zhang, H., Moghaddam, A., Bicknell, R., Talbot, D., Stratford, I. and Harris, A. (1994) Increased sensitivity to the pro-drug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cell transfected with thymidine Phosphorylase. Cancer Res. submitted.
Paweletz, N. and Knierim, M. (1989) Tumor-related angiogenesis. Crit. Rev. Oncol. Hematol. 9(3): 197–242.
Pepper, M.S., Belin, D., Montesano, R., Orci, L. and Vassalli, J.D. (1990) Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111 (2): 743–755.
Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181 (2): 902–906.
Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189(2): 824–831.
Peters-Engl, C, Medi, M. and Leodolter, S. (1995) The use of colour-coded and spectral Doppler ultrasound in the differentiation of benign and malignant breast lesions. Br. J. Cancer 71(1): 137–139.
Plate, K.H., Breier, G., Weich, H.A. and Risau, W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359(6398): 845–848.
Pober, J.S. (1988) Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am. J. Pathol. 133 (3): 426–433.
Polette, M., Clavel, C, Birembaut, P. and De, C.Y. (1993 a) Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol. Res. Pract. 189(9): 1052–1057.
Polette, M., Clavel, C, Cockett, M., Girod, d. B.S., Murphy, G. and Birembaut, P. (1993b) Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 13 (1): 31–37.
Polverini, P.J. and Leibovich, S.J. (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest. 51 (6): 635–642.
Porschen, R., Classen, S., Piontek, M. and Borchard, F. (1994) Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res. 54(2): 587–591.
Porter, PL., Patton, K.F., Self, S.A., Gown, A.M. and Schmidt, R.A. (1993) A quantitative study of blood vessel size and density in normal and neoplastic breast tissue. Mod. Pathol. 6:18; USCAP Abstract 87.
Postlethwaite, A.E., Snyderman, R. and Ang, A.H. (1976) The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J. Exp. Med. 144:1188–1203.
Poulsom, R., Pignatelli, M., Stetler, S.W., Liotta, L.A., Wright, P.A., Jeffery, R.E., Longeron, J.M., Rogers, L. and Stamp, G.W. (1992) Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol. 141(2): 389–396.
Poulsom, R., Hanby, A.M., Pignatelli, M., Jeffery, R.E., Longeron, J.M., Rogers, L. and Stamp, G.W. (1993) Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J. Clin. Pathol. 46(5):429–436.
Protopapa, E., Delides, G.S. and Revesz, L. (1993) Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Eur. J. Cancer.
Rastinejad, F., Polverini, P.J. and Bouck, N.P. (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56(3): 345–355.
Renkonen, R., Paavonen, T., Nortamo, P. and Gahmberg, C.G. (1992) Expression of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am. J. Pathol. 140(4): 763–767.
Reynolds, K., Farzaneh, F, Collins, W.P., Campbell, S., Bourne, T.H., Lawton, F, Moghaddam, A., Harris, A.L. and Bicknell, R. (1994a) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst. 86(16): 1234–1238.
Reynolds, K., Farzaneh, F., Collins, WP, Campbell, S., Bourne, T.H., Lawton, F, Moghaddam, A., Harris, A.L. and Bicknell, R (1994 b) Correlation of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst., in press.
Roberts, W. and Bevilacqua, M. (1994) Vascular endothelial growth factor inhibits E-selectin and VCAM-1 expression in vitro and in vivo. J. Cell. Biochem. suppl. 18 A: 329 (abstract).
Rochefort, H. (1990) Biological and clinical significance of cathepsin D in breast cancer. Semin. Cancer Biol. 1:153–160.
Roy, J., Platt, J.L. and Weisdorf, D.J. (1993) The immunopathology of upper gastrointestinal acute graft-versus-host disease. Lymphoid cells and endothelial adhesion molecules. Transplantation 55(3):572–578.
Rubbert, A., Manger, B., Lang, N., Kalden, J.R. and Platzer, F. (1991) Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocyts and peripheral-blood lymphocytes from patients with breast cancer. Int. J. Cancer 49(1): 25–31.
Ruco, L.P, Pomponi, D., Pigott, R., Stoppacciaro, A., Monardo, F., Uccini, S., Boraschi, D., Tagliabue, A., Santoni, A., Dejana, E., Mantovani, A. and Baroni, CD. (1990) Cytokine production (IL-1 α, IL-1 ß, and TNF α) end endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin’s disease, and in non-Hodgkin’s lymphomas. An immunocytochemical study. Am. J. Pathol. 137(5): 1163–1171.
Rutgers, J.L., Matrox, T.F. and Vargas, M.P (1995) Angiogenesis in uterine cervical squamous cell carcinoma. Int. J. Gynecol. Pathol. 14:114–118.
Sahin, A., Sneige, N., Singletary, E. and Ayala, A. (1992) Tumor angiogenesis detected by Factor-VIII immunostaining in node-negative breast carcinoma (NNBC): a possible predictor of distant metastasis. Mod. Pathol. 5:17 A (abstract).
Samejima, N. and Yamazaki, K. (1988) A study on the vascular proliferation in tissues around the tumor in breast cancer. Jpn. J. Surg. 18:235–242.
Samoto, K., Ikezaki, K., Ono, M., Shono, T., Kohno, K., Kuwano, M. and Fukui, M. (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 55 (5): 1189–1193.
Sato, T, Akiyama, F., Sakamoto, G., Kasumi, F. and Nakamura, Y (1991) Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 51 (21): 5794–5799.
Schadendorf, D., Heidel, J., Gawlik, C, Suter, L. and Czarnetzki (1995) Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J. Natl. Cancer Inst. 87: 366–371.
Schmitt, M., Jänicke, F. and Graeff, H. (1990) Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer. Blood Coag. Fibrino. 1:695–702.
Schultz-Hector, S. and Haghayegh, S. (1993) B-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res. 53:1444–1449.
Schweigerer, L., Malerstein, B. and Gospodarowicz, D. (1987) Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem. Biophys. Res. Commun. 143 (3): 997–1004.
Scott, P.A. and Harris, A.L. (1994) Current approaches to targeting cancer using antiangiogenesis therapies. Cancer Treat. Rev. 20(4): 393–412.
Senger, D.R., Van, d. W.L., Brown, L.F., Nagy, J.A., Yeo, K.T., Yeo, T.K., Berse, B., Jackman, R.W., Dvorak, A.M. and Dvorak, H.F. (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12(3–4): 303–324.
Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L. and Schuh, A.C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376(6535): 62–66.
Sheid, B. (1992) Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer. Cancer Lett. 62 (2): 153–158.
Shweiki, D., Itin, A., Soffer, D. and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398): 843–845.
Sightler, H., Borowsky, A., Dupont, W., Page, D. and Jensen, R. (1994) Evaluation of tumor angiogenesis as a prognostic marker in breast cancer. Lab. Invest. 70:22 A (abstract).
Simpson, J., Ahn, C, Battifora, H. and Esteban, J. (1994) Vascular surface area as a prognostic indicator in invasive breast carcinoma. Lab. Invest. 70:22 A (abstract).
Smith, H.S., Lu, Y, Deng, G., Martinez, O., Kramms, S., Ljung, B.M., Thor, A. and Lagios, M. (1993) Molecular aspects of early stages of breast cancer progression. J. Cell. Biochem. Suppl.
Smith-McCune, K. and Weidner, N. (1994) Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res. 54:800–804.
Smolle, J., Soyer, H.P., Hofmann-Wellenhof, Smolle-Juettner, F.M. and Kerl, H. (1989) Vascular architecture of melanocytic skin tumors. Path. Res. Pract. 185:740–745.
Springer, T.A. (1990) Adhesion receptors of the immune system. Nature 346(6283): 425–434.
Spyratos, F., Maudelonde, T., Brouillet, J.-P., Brunet, M., Defrenne, A., Andrieu, C, Hacene, K., Desplaces, A., Rouëssé, J. and Rochefort, H. (1989) Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 8672:1115–1118.
Spyratos, F, Martin, P.M., Hacene, K., Romain, S., Andrieu, C, Ferrerò, P.M., Deytieux, S., Le, D.V, Tubiana, H.M. and Brunet, M. (1992) Multiparametric prognostic evaluation of biological factors in primary breast cancer. J. Natl. Cancer Inst. 84(16): 1266–1272.
Srivastava, A., Webster, D.J., Woodcock, J.P., Shrotria, S., Mansel, R.E. and Hughes, L.E. (1988) Role of Doppler ultrasound flowmetry in the diagnosis of breast lumps. Br. J. Surg. 75(9):851–853.
Stein, I., Neeman, M., Shweiki, D., Itin, A. and Keshet, E. (1995) Stabilization of vascular endothelial growth factor mRNA be hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15(10):363–5368.
Steinhoff, G., Behrend, M. and Haverich, A. (1991) Signs of endothelial inflammation in human heart allografts. Eur. Heart J. 12 Suppl. D: 141–143.
Strasser, A. Harris, A.W., Bath, M.L. and Cory, S. (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348(6299):.331–333.
Stratton, M.R., Collins, N., Lakhani, S.R. and Sloane, J.P. (1995) Loss of heterozygosity in ductal carcinoma in situ of the breast. J. Pathol. 175 (2): 195–201.
Sumiyoshi, K., Baba, S., Sakaguchi, S., Urano, T., Takada, Y. and Takada, A. (1991) Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumour progression and metastasis. Thrombosis Res. 63:59–71.
Sumizawa, T., Furikawa, T., Haraguchi, M., Yoshimura, A., Takeyasu, A., Ishizawa, M., Yamada, Y. and Akiyama, S. (1993) Thymidine Phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem. Tokyo 114(1):9–14.
Sunderkotter, C, Steinbrink, K., Goebeler, M., Bhardwaj, R. and Sorg, C. (1994) Macrophages and angiogenesis. J. Leukoc. Biol. 55 (3): 410–422.
Sutherland, R.M. (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240(4849): 177–184.
Sutherland, R.M., McCredie, J.A. and Inch, W.R. (1971) Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl Cancer Inst. 46(1): 113–120.
Srivastava, A., Leidler, R, Davies, R., Horgan, K. and Hughes, L. (1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 thick) skin melanoma. Am. J. Pathol. 133:419–423.
Takashashi, A., Sasaki, H., Kim, S.J., Tobisu, K., Kakizoe, T, Tsukamoto, T, Kumamoto, Y., Sugimura, T. and Terada, M. (1994) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 54 (15):4233–4237.
Takahashi, Y, Kitadai, Y, Bucana, CD., Cleary, K.R. and Ellis, L.M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. 55:3964–3968.
Tandon, A., Clark, G.M., Chamness, G.C, Chirgwin, J.M. and McGuire, W.L. (1990) Cathepsin D and prognosis in breast cancer. N Engl J. Med. 322:297–302.
Tang, D.G., Chen, Y.Q., Newman, P.J., Shi, L., Gao, X., Diglio, CA. and Honn, K.V (1993) Identification of PEC AM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J. Biol. Chem. 268 (30): 22883–22894.
Terman, B.I., Dougher, VM., Carrion, M.E., Dimitrov, D., Armellino, D.C, Gospodarowicz, D. and Bohlen, P. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187(3): 1579–1586.
Tessler, S., Rockwell, P., Hicklin, D., Cohen, T, Levi, B.Z., Witte, L., Lemischka, I.R. and Neufeld, G. (1994) Heparin modulates the interaction of VEGF 165 with soluble and cell associated flk-1 receptors. J. Biol Chem. 269(17): 12456–12461.
Thompson, T.C, Southgate, J., Kitchener, G. and Land, H. (1989) Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56(6): 917–930.
Toi, M., Kashitani, J. and Tominaga, T. (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer 55 (3): 371–374.
Toi, M., Hoshina, S., Takayanagi, T. and Tominaga, T. (1994) Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res. 85(10): 1045–1049.
Toi, M., Hoshina, S., Taniguchi, T, Yamamoto, Y, Ishitsuka, H. and Tominaga, T. (1995) Expression of platelet-derived endothelial cell growth factor/thymidine Phosphorylase in human breast cancer. Int. J. Cancer 64(2): 79–82.
Tuszynski, G.P. and Nicosia, R.F. (1994) Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab. Invest. 70(2):228–233.
Uria, J.A., Ferrando, A.A., Velasco, G., Freije, J.M. and Lopez, O.C (1994) Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 54 (8): 2091–2094.
Usuki, K., Saras, J., Waltenberger, J., Miyazono, K., Pierce, G., Thomason, A. and Heldin, CH. (1992) Platelet-derived endothelial cell growth factor has thymidine Phosphorylase activity. Biochem. Biophys. Res. Commun. 184 (3): 1311–1316.
van der Wal, A.C., Das, PK., Tigges, A.J. and Becker, A.E. (1992) Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesion. Am. J. Pathol. 141 (6):1427–1433.
Van Hoef, M.E., Knox, W.F., Dhesi, S.S., Howell, A. and Schor, A.M. (1993) Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer 29 A(8): 1141–1145.
Van, M.E., Polverini, P.J., Chazin, VR., Su, H.H., de, T.N. and Cavenee, WK. (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8(2): 171–176.
Vaporciyan, A.A., DeLisser, H.M., Yan, H.C, Mendiguren, I.I., Thorn, S.R., Jones, M.L., Ward, P.A. and Albelda, S.M. (1993) Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262(5139): 1580–1582.
Vaupel, P, Kallinowski, F. and Okunieff, P. (1989) Blood flow, oxygen and nutrient supply and metabolis microenvironment of human tumors: a review. Cancer Res. 49(23): 6449–6465.
Vesalainen, S., Lipponen, P., Talja, M., Alhava, E. and Syrjanen, K. (1994) Tumor vascularity and basement membrane structure as prognostic factors in T1–2M0 prostatic adenocarcinoma. Anticancer Res. 14:709–714.
Vignon, F., Capony, F, Chambón, M., Freiss, G., Garcia, M. and Rochefort, H. (1986) Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology 118:1537–1545.
Visscher, D., Smilanetz, S., Drozdowicz, S. and Wykes, S. (1993) Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal. Quant. Cytol. 15:88–92.
Visscher, D., DeMattia, F. and Boman, S. (1994) Technical factors affecting image morphometric microvessel density counts in breast carcinomas. Lab. Invest. 70:168 A (abstract).
Visscher, D.W., DeMattia, F., Ottosen, S., Sarkar, F.H. and Crissman, J.D. (1995) Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod. Pathol. 8:665–670.
Vlodavsky, I., Korner, G., Ishai, M.R., Bashkin, P., Bar, S.R. and Fuks, Z. (1990) Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 9 (3): 203–226.
Volpert, O.V, Stellmach, V and Bouck, N. (1995) The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat. 36:119–126.
Volpes, R., Van, D.O.J, and Desmet, V.J. (1992) Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 15 (2): 269–275.
Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S. and Ushigome, S. (1992) Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J. Pathol. 168(3):257–262.
Waltenberger, J., Claesson, W.L., Siegbahn, A., Shibuya, M. and Heldin, C.H. (1994) Different signal transduction properties of KDR and Fit 1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269(43):26988–26995.
Warren, B. (1979) The vascular morphology of tumors. In: H. Peterson (ed.): Tumor Blood Circulation. CRC Press, Boca Raton, 1–47.
Warren, B. A. and Shubik, P. (1966) The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab. Invest. 15:464–478.
Weidner, N. and Gasparini, G. (1994) Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients. Breast Cancer Res. Treat. 29:97–108.
Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324(1):1–8.
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E.N. Moore, D.H., Meli, S. and Gasparini, G. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [see comments]. J. Natl. Cancer Inst. 84(24): 1875–1887.
Weidner, N., Carroll, PR., Flax, J., Blumenfeld, W. and Folkman, J. (1993) Tumor angio-genesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143(2): 401–409.
Weidner, N., Gasparini, G., Bevilacqua, P., Maluta, S., Palma, P., Caffo, O., Barbareschi, M., Borrachi, P., Marubini, E. and Pozza, F. (1994) Tumor microvessel density, p53 expression, and tumor size are relevant prognostic markers in node negative breast carcinomas. Lab. Invest. 70: A 24 (abstract).
Weindel, K., Moringlane, J.R., Marme, D. and Weich, H.A. (1994) Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35 (3): 439–448.
Weinstat, S.D. and Steeg, P.S. (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J. 8 (6): 401–407.
Wesseling, P., Vandersteenhoven, J.J., Downey, B.T., Ruiter, D.J. and Burger, PC. (1993) Cellular components of microvascular proliferation inhuman glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material. Acta Neuropathol. (Berl) 85 (5): 508–514.
Wiggins, D.L., Granai, CO., Steinhoff, M.M. and Calabresi, P. (1995) Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 56(3): 353–356.
Williams, G.T. (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65(7): 1097–1098.
Williams, J.K., Carlson, G.W, Cohen, C, Derose, P.B., Hunter, S. and Jurkiewicz, M.J. (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am. J. Surg. 168(5): 373–380.
Winstanley, J., Leinster, S.J., Cooke, T.G., Westley, B.R., Platt-Higins, A.M. and Rudland, P.S. (1993) Prognostic significance of cathepsin-D in patients with breast cancer. Br. J. Cancer. 67:767–772.
Wong, S.Y., Purdie, A.T. and Han, P. (1992) Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. Am. J. Pathol. 140(6): 1473–1382.
Wu, C.C, Lee, C.N., Chen, T.M., Shyu, M.K., Hsieh, C.Y., Chen, H.Y and Hsieh, F.J. (1994) Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 73 (4): 1251–1256.
Yamaguchi, TP, Dumont, D.J., Conlon, R.A., Breitman, M.L. and Rossant, J. (1993) flk-1, an fit-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118 (2): 489–498.
Zabrenetzky, V, Harris, C.C, Steeg, P.S. and Roberts, D.D. (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59:191–195.
Zagzag, D., Brem, S. and Robert, F. (1988) Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. Am. J. Pathol 131 (2): 361–372.
Zajchowski, D.A., Band, V, Trask, D.K., Kling, D., Connolly, J.L. and Sager, R. (1990) Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc. Natl Acad. Sci. USA 87(6): 2314–2318.
Zarnegar, R. and DeFrances, M.C (1993) Expression of HGF-SF in normal and malignant human tissues. EXS 65 (181): 181–199.
Zetter, B.R. (1993) Adhesion molecules in tumor metastasis. Semin. Cancer Biol 4(4):219–229.
Zhang, H.T., Craft, P., Scott, P.A., Ziehe, M., Weich, H.A., Harris, A.L. and Bicknell, R. (1995) Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst. 7(3):213–219.
Ziehe, M. and Gullino, P.M. (1982) Angiogenesis and neoplastic progression in vitro. J. Natl. Cancer Inst. 69 (2): 483–487.
Zocchi, M.R. and Poggi, A. (1993) Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas [letter]. J. Natl. Cancer Inst. 85 (3): 246–247.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Birkhäuser Verlag Basel, Switzerland
About this chapter
Cite this chapter
Engels, K., Fox, S.B., Harris, A.L. (1997). Angiogenesis as a biologic and prognostic indicator in human breast carcinoma. In: Goldberg, I.D., Rosen, E.M. (eds) Regulation of Angiogenesis. Experientia Supplementum, vol 79. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-9006-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-0348-9006-9_6
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-9864-5
Online ISBN: 978-3-0348-9006-9
eBook Packages: Springer Book Archive